Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 9 | 2013 | 1621 | 0.870 |
Why?
|
| Polymorphism, Single Nucleotide | 16 | 2015 | 2357 | 0.750 |
Why?
|
| Genotype | 10 | 2015 | 1851 | 0.700 |
Why?
|
| Genetics, Population | 6 | 2015 | 394 | 0.460 |
Why?
|
| Haplotypes | 6 | 2015 | 642 | 0.410 |
Why?
|
| Genome, Human | 6 | 2015 | 756 | 0.370 |
Why?
|
| Biostatistics | 1 | 2010 | 20 | 0.370 |
Why?
|
| Algorithms | 3 | 2012 | 1830 | 0.360 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2008 | 101 | 0.320 |
Why?
|
| Models, Genetic | 6 | 2015 | 926 | 0.270 |
Why?
|
| Gene Frequency | 4 | 2015 | 677 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2012 | 2271 | 0.160 |
Why?
|
| Genetic Variation | 4 | 2015 | 1351 | 0.130 |
Why?
|
| Schizophrenia | 2 | 2008 | 464 | 0.130 |
Why?
|
| Software | 2 | 2009 | 654 | 0.130 |
Why?
|
| Amidinotransferases | 1 | 2013 | 5 | 0.120 |
Why?
|
| Linkage Disequilibrium | 4 | 2009 | 473 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 853 | 0.120 |
Why?
|
| Alleles | 3 | 2015 | 1128 | 0.120 |
Why?
|
| INDEL Mutation | 1 | 2013 | 30 | 0.110 |
Why?
|
| Muscular Diseases | 1 | 2013 | 63 | 0.110 |
Why?
|
| Simvastatin | 1 | 2013 | 106 | 0.110 |
Why?
|
| Computational Biology | 2 | 2015 | 528 | 0.110 |
Why?
|
| Human Genome Project | 1 | 2012 | 19 | 0.110 |
Why?
|
| Models, Statistical | 1 | 2015 | 574 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2011 | 15 | 0.100 |
Why?
|
| Selection, Genetic | 1 | 2015 | 502 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2011 | 37 | 0.100 |
Why?
|
| Databases, Genetic | 1 | 2012 | 260 | 0.100 |
Why?
|
| Evolution, Molecular | 2 | 2015 | 813 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 179 | 0.090 |
Why?
|
| Quantitative Trait Loci | 1 | 2013 | 576 | 0.090 |
Why?
|
| Hemoglobin, Sickle | 1 | 2009 | 19 | 0.090 |
Why?
|
| Malaria | 1 | 2009 | 23 | 0.090 |
Why?
|
| Humans | 16 | 2015 | 86643 | 0.090 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 378 | 0.090 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2008 | 12 | 0.080 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2008 | 93 | 0.080 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2007 | 16 | 0.080 |
Why?
|
| Case-Control Studies | 5 | 2012 | 1805 | 0.080 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2007 | 24 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2012 | 535 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 297 | 0.070 |
Why?
|
| Autoimmunity | 1 | 2007 | 160 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 689 | 0.070 |
Why?
|
| Chromosome Mapping | 4 | 2012 | 1074 | 0.070 |
Why?
|
| Multiple Sclerosis | 1 | 2007 | 262 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1920 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 938 | 0.060 |
Why?
|
| Genomics | 1 | 2007 | 720 | 0.050 |
Why?
|
| Italy | 1 | 2015 | 106 | 0.030 |
Why?
|
| United Kingdom | 1 | 2015 | 164 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2015 | 361 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2013 | 3 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 2903 | 0.030 |
Why?
|
| Mutation Rate | 1 | 2013 | 48 | 0.030 |
Why?
|
| Fathers | 1 | 2013 | 70 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 236 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 2013 | 111 | 0.030 |
Why?
|
| Mothers | 1 | 2013 | 141 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2012 | 24 | 0.030 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2012 | 36 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 6509 | 0.030 |
Why?
|
| Cholesterol | 1 | 2013 | 356 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2013 | 464 | 0.030 |
Why?
|
| Reference Standards | 1 | 2012 | 159 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2015 | 1078 | 0.020 |
Why?
|
| Aged | 3 | 2015 | 18415 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2012 | 250 | 0.020 |
Why?
|
| Young Adult | 2 | 2015 | 5976 | 0.020 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2011 | 124 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2012 | 623 | 0.020 |
Why?
|
| Exons | 1 | 2012 | 450 | 0.020 |
Why?
|
| Gambia | 1 | 2009 | 2 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 456 | 0.020 |
Why?
|
| Middle Aged | 3 | 2015 | 25028 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 2468 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2008 | 47 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 1135 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2008 | 87 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 674 | 0.020 |
Why?
|
| Aminopeptidases | 1 | 2007 | 17 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2007 | 39 | 0.020 |
Why?
|
| Receptors, Interleukin | 1 | 2007 | 35 | 0.020 |
Why?
|
| North America | 1 | 2007 | 180 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2007 | 135 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2012 | 567 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2007 | 476 | 0.020 |
Why?
|
| Bipolar Disorder | 1 | 2008 | 377 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2012 | 730 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 927 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 819 | 0.020 |
Why?
|
| Male | 3 | 2013 | 40965 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1801 | 0.010 |
Why?
|
| Adult | 2 | 2015 | 25648 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 8981 | 0.010 |
Why?
|
| Child | 1 | 2013 | 6927 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 1373 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 3640 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 3241 | 0.010 |
Why?
|
| Female | 2 | 2013 | 44532 | 0.010 |
Why?
|